annual cash & cash equivalents:
$399.76M+$127.98M(+47.09%)Summary
- As of today (May 29, 2025), VRNA annual cash & cash equivalents is $399.76 million, with the most recent change of +$127.98 million (+47.09%) on December 31, 2024.
- During the last 3 years, VRNA annual cash & cash equivalents has risen by +$251.38 million (+169.41%).
- VRNA annual cash & cash equivalents is now at all-time high.
Performance
VRNA Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$401.42M+$1.66M(+0.41%)Summary
- As of today (May 29, 2025), VRNA quarterly cash & cash equivalents is $401.42 million, with the most recent change of +$1.66 million (+0.41%) on March 31, 2025.
- Over the past year, VRNA quarterly cash & cash equivalents has increased by +$146.53 million (+57.49%).
- VRNA quarterly cash & cash equivalents is now -0.79% below its all-time high of $404.60 million, reached on June 30, 2024.
Performance
VRNA quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
VRNA Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +47.1% | +57.5% |
| 3 y3 years | +169.4% | +202.3% |
| 5 y5 years | +1213.8% | +1517.8% |
VRNA Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +169.4% | -0.8% | +260.0% |
| 5 y | 5-year | at high | +1213.8% | -0.8% | +1703.7% |
| alltime | all time | at high | >+9999.0% | -0.8% | >+9999.0% |
VRNA Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $401.42M(+0.4%) |
| Dec 2024 | $399.76M(+47.1%) | $399.76M(+19.0%) |
| Sep 2024 | - | $336.04M(-16.9%) |
| Jun 2024 | - | $404.60M(+58.7%) |
| Mar 2024 | - | $254.88M(-6.2%) |
| Dec 2023 | $271.77M(+19.3%) | $271.77M(+5.6%) |
| Sep 2023 | - | $257.37M(-4.9%) |
| Jun 2023 | - | $270.73M(-7.1%) |
| Mar 2023 | - | $291.42M(+27.9%) |
| Dec 2022 | $227.83M(+53.5%) | $227.83M(-1.7%) |
| Sep 2022 | - | $231.70M(+107.8%) |
| Jun 2022 | - | $111.51M(-16.0%) |
| Mar 2022 | - | $132.76M(-10.5%) |
| Dec 2021 | $148.38M(-21.1%) | $148.38M(-10.9%) |
| Sep 2021 | - | $166.55M(+14.0%) |
| Jun 2021 | - | $146.03M(-13.9%) |
| Mar 2021 | - | $169.60M(-9.8%) |
| Dec 2020 | $187.99M(+517.8%) | $187.99M(-6.9%) |
| Sep 2020 | - | $201.97M(+807.5%) |
| Jun 2020 | - | $22.26M(-10.3%) |
| Mar 2020 | - | $24.81M(-18.5%) |
| Dec 2019 | $30.43M(+21.2%) | $30.43M(-26.8%) |
| Sep 2019 | - | $41.58M(+46.2%) |
| Jun 2019 | - | $28.43M(+16.4%) |
| Mar 2019 | - | $24.42M(-2.7%) |
| Dec 2018 | $25.10M | $25.10M(-30.1%) |
| Sep 2018 | - | $35.91M(-24.9%) |
| Jun 2018 | - | $47.82M(+17.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $40.66M(-4.3%) |
| Dec 2017 | $42.49M(-13.4%) | $42.49M(+1.0%) |
| Sep 2017 | - | $42.06M(-48.4%) |
| Jun 2017 | - | $81.46M(+66.0%) |
| Dec 2016 | $49.09M(+840.1%) | $49.09M(+2950.0%) |
| Jun 2016 | - | $1.61M(-69.2%) |
| Dec 2015 | $5.22M(-66.4%) | $5.22M(-45.5%) |
| Jun 2015 | - | $9.58M(-38.2%) |
| Dec 2014 | $15.52M(+1458.6%) | $15.52M(-24.7%) |
| Jun 2014 | - | $20.61M(+1969.9%) |
| Dec 2013 | $995.60K(-35.9%) | $995.60K(-29.6%) |
| Jun 2013 | - | $1.41M(-8.9%) |
| Dec 2012 | $1.55M(-60.4%) | $1.55M(-58.0%) |
| Jun 2012 | - | $3.70M(-5.6%) |
| Dec 2011 | $3.92M(+26.9%) | $3.92M(+112.2%) |
| Jun 2011 | - | $1.85M(-40.2%) |
| Dec 2010 | $3.09M(-32.4%) | $3.09M(-29.4%) |
| Jun 2010 | - | $4.38M(-4.4%) |
| Dec 2009 | $4.58M(+27.3%) | $4.58M(+66.3%) |
| Jun 2009 | - | $2.75M(-23.4%) |
| Dec 2008 | $3.60M(+44.8%) | $3.60M(-42.9%) |
| Jun 2008 | - | $6.30M(+153.8%) |
| Dec 2007 | $2.48M(+19.2%) | $2.48M(-33.4%) |
| Jun 2007 | - | $3.73M(+78.9%) |
| Dec 2006 | $2.08M(+23.3%) | $2.08M(+30.6%) |
| Jun 2006 | - | $1.59M(-5.6%) |
| Dec 2005 | $1.69M | $1.69M(-5.8%) |
| Jun 2005 | - | $1.79M |
FAQ
- What is Verona Pharma annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Verona Pharma?
- What is Verona Pharma annual cash & cash equivalents year-on-year change?
- What is Verona Pharma quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Verona Pharma?
- What is Verona Pharma quarterly cash & cash equivalents year-on-year change?
What is Verona Pharma annual cash & cash equivalents?
The current annual cash & cash equivalents of VRNA is $399.76M
What is the all time high annual cash & cash equivalents for Verona Pharma?
Verona Pharma all-time high annual cash & cash equivalents is $399.76M
What is Verona Pharma annual cash & cash equivalents year-on-year change?
Over the past year, VRNA annual cash & cash equivalents has changed by +$127.98M (+47.09%)
What is Verona Pharma quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of VRNA is $401.42M
What is the all time high quarterly cash & cash equivalents for Verona Pharma?
Verona Pharma all-time high quarterly cash & cash equivalents is $404.60M
What is Verona Pharma quarterly cash & cash equivalents year-on-year change?
Over the past year, VRNA quarterly cash & cash equivalents has changed by +$146.53M (+57.49%)